Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, April 16, 2020
[ Thu, Apr 16th 2020
] - WOPRAI
[ Thu, Apr 16th 2020
] - WOPRAI
[ Thu, Apr 16th 2020
] - WOPRAI
[ Thu, Apr 16th 2020
] - WOPRAI
[ Thu, Apr 16th 2020
] - WOPRAI
[ Thu, Apr 16th 2020
] - WOPRAI
[ Thu, Apr 16th 2020
] - WOPRAI
[ Thu, Apr 16th 2020
] - WOPRAI
[ Thu, Apr 16th 2020
] - WOPRAI
[ Thu, Apr 16th 2020
] - WOPRAI
[ Thu, Apr 16th 2020
] - WOPRAI
[ Thu, Apr 16th 2020
] - WOPRAI
[ Thu, Apr 16th 2020
] - WOPRAI
[ Thu, Apr 16th 2020
] - WOPRAI
Wed, April 15, 2020
[ Wed, Apr 15th 2020
] - WOPRAI
[ Wed, Apr 15th 2020
] - WOPRAI
[ Wed, Apr 15th 2020
] - WOPRAI
[ Wed, Apr 15th 2020
] - WOPRAI
[ Wed, Apr 15th 2020
] - WOPRAI
[ Wed, Apr 15th 2020
] - WOPRAI
[ Wed, Apr 15th 2020
] - WOPRAI
[ Wed, Apr 15th 2020
] - WOPRAI
[ Wed, Apr 15th 2020
] - WOPRAI
[ Wed, Apr 15th 2020
] - WOPRAI
[ Wed, Apr 15th 2020
] - WOPRAI
[ Wed, Apr 15th 2020
] - WOPRAI
[ Wed, Apr 15th 2020
] - WOPRAI
[ Wed, Apr 15th 2020
] - WOPRAI
Matthew Harrison Maintained (BLUE) at Hold with Decreased Target to $69 on, Apr 15th, 2020
Matthew Harrison of Morgan Stanley, Maintained "bluebird bio, Inc." (BLUE) at Hold with Decreased Target from $92 to $69 on, Apr 15th, 2020.
Matthew has made no other calls on BLUE in the last 4 months.
There are 2 other peers that have a rating on BLUE. Out of the 2 peers that are also analyzing BLUE, 0 agree with Matthew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Matthew
- Benjamin Burnett of "Stifel" Upgraded from Hold to Strong Buy and Decreased Target to $70 on, Friday, March 27th, 2020
- Joshua Schimmer of "Evercore ISI Group" Upgraded from Hold to Buy and Increased Target to $100 on, Monday, February 3rd, 2020
